Details of Viral Vaccine
This Viral vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 10018 |
| Vaccine Name | JCOVDEN |
| Disease Name | COVID-19 |
| Disease Classification | Respiratory |
| Virus Name | SARS-CoV-2 virus |
| Nucleic Acid Content | positive-sense, single-stranded RNA |
| Vaccine Type | Recombinant viral vector |
| Vaccine Status | Approved |
| Manufacturer | Johnson & Johnson |
| Year of Manufacturing | 2021 |
| Manufacturing Country | USA |
| Age | 18 - 65 years |
| Dosage | Single dose |
| Administration Route | Intramuscular |
| Adjuvant | NA |
| Target Strain | Spike protein of SARS-CoV-2 virus |
| Description | NA |
| Approving Organisation | US FDA, WHO |
| Collaborating Organisation | NA |
| Other Countries | Netherlands, USA, Argentina, Brazil, Chile, Colombia, Mexico, Peru, Philippines, South Africa, Ukraine, Belgium, Colombia, France, Germany, Philippines, Spain, UK, Europe |
| Trade Name | Ad26.COV2.S, JNJ-78436735,Ad26COVS1, VAC31518,COVID-19 Vaccine Janssen,Johnson & Johnson COVID‑19 vaccine |
| PMID | 32328406 |
| Clinical Trial ID | NCT04927936 |
| Reference Link | https://pubmed.ncbi.nlm.nih.gov/32328406/ |
| Additional Links | https://www.ema.europa.eu/en/documents/product-information/jcovden-previously-covid-19-vaccine-janssen-epar-product-information_en.pdf |